|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Platinum (soluble salts, as Pt) | CAS | ||
|
|
RTECS | ||
|
Synonyms & Trade Names Synonyms vary depending upon the specific soluble platinum salt. |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.002 mg/m3 | ||
| OSHA PEL: TWA 0.002 mg/m3 | |||
| IDLH 4 mg/m3 (as Pt) | Conversion | ||
|
Physical Description Appearance and odor vary depending upon the specific soluble platinum salt. |
|||
|
Properties vary depending upon the specific soluble platinum salt. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incompatibilities & Reactivities Varies |
|||
|
Measurement Methods NIOSH 7300, S191 (II-7) |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 0.05 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode� Up to 0.1 mg/m3: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Up to 4 mg/m3: (APF = 2000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, nose; cough, dyspnea (breathing difficulty), wheezing, cyanosis; dermatitis, sensitization skin; lymphocytosis | |
|
Target Organs
Eyes, skin, respiratory system |
|
| See also: INTRODUCTION |